SOPHiA GENETICS (SOPH) CMO Philippe Menu Sells 5,000 Shares

What Happened Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 5,000 common shares on 2026-09-14. The transaction was reported at a weighted average price of $7.88 per share for total proceeds of approximately $39,417. This was a sale (not a purchase or option exercise).

Key Details

• Transaction date: 2026-09-14; Form 4 filed: 2026-09-16 (appears timely).
• Shares sold: 5,000 at a weighted average price of $7.88; total value ≈ $39,417.
• Price range: shares were sold in multiple trades at prices from $7.78 to $7.99 (footnote).
• Footnotes: Transaction made pursuant to a Rule 10b5-1 trading plan (pre-arranged plan). The reporting person will provide, upon request, the number of shares sold at each separate price within the stated range.
• Shares owned after the transaction: Not disclosed in the provided filing extract.

Context This sale was executed under a 10b5-1 plan, which is a pre-arranged trading program often used to avoid timing concerns; such sales are generally considered routine and do not by themselves signal management’s view of the company. For retail investors, purchases typically convey stronger actionable information than routine sales. If you need a price-by-price breakdown or outstanding ownership details, the filer indicates those specifics are available upon written request or can be found in the full SEC filing.